ライフサイエンスコーパス: osteogenic

1 erm culture-induced MSC aging impaired their osteogenic ability and subsequent bony callus formation,

2 ous parathyroid hormone (PTH) blocks its own osteogenic actions in marrow stromal cell cultures by in

3 mBMSCs with Msx1 and Msx2 genes and compared osteogenic activity and expression levels of several Msx

4 Osteogenic activity in the aortic valve is under the con

5 olecular strategies are toward promoting pro-osteogenic activity of BMP2 while simultaneously suppres

6 l revealed distinct phases of osteolytic and osteogenic activity, a critical role for mesenchymal str

7 RO5444101 decreased osteogenic activity.

8 perivascular progenitor cell line that lacks osteogenic, adipogenic and angiogenic potential but is c

9 eins are potent stem cell activators and pro-osteogenic agents.

10 ure, resulting in derepression of latent pro-osteogenic and -inflammatory gene networks.

11 ir stem cell character demonstrated by their osteogenic and adipogenic differentiation capacity and t

12 in tethering, substrate deformations, or the osteogenic and adipogenic differentiation of human adipo

13 g epigenetic modifications that occur during osteogenic and adipogenic differentiation of mouse bone

14 ompared the inter-donor variability of their osteogenic and adipogenic differentiation potential, as

15 s from calcification in vivo, activated anti-osteogenic and anti-inflammatory networks in NOTCH1(+/+)

16 Collectively, CypA dually exerts pro-osteogenic and anti-osteoclastic effects.

17 pression and gene silencing of CypA verified osteogenic and anti-osteoclastic effects.

18 ferentiation by staining for the presence of osteogenic and chondrogenic cells.

19 istinct subpopulation of MSCs, with enhanced osteogenic and decreased adipogenic differentiation capa

20 scription factor 2-mediated (Runx2-mediated) osteogenic and decreased PPARgamma-dependent adipogenic

21 This process is thought to impair osteogenic and hematopoietic regeneration.

22 concentration for microspheres, the combined osteogenic and mineralization effect of PRP and BMP2 on

23 differentiation of mesenchymal cells to the osteogenic and myoblastic lineages.

24 aphy, cell shape and cell differentiation to osteogenic and myogenic lineages.

25 , the authors compared and evaluated the pro-osteogenic and pro-odontogenic effects of 4 small bioact

26 ssive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocu

27 Cs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential.

28 progenitors, through the generation of both osteogenic and stromal cells, provide a supportive envir

29 helial growth factor (VEGF) on the extent of osteogenic and vasculogenic differentiation of human mes

30 ys from NG(21) resulted in highest extent of osteogenic and vasculogenic differentiation of the encap

31 ines, including proinflammatory TGFbeta1 and osteogenic BMP-2, as well as glycosaminoglycans such as

32 BMP4 overexpression in non-osteogenic C4-2b PCa cells led to ectopic bone formation

33 ts on cell viability, or on their subsequent osteogenic capabilities.

34 Cpdm primary calvarial cells display reduced osteogenic capacity ex vivo, and the same was observed w

35 afts from aged animals with L-WNT3A restored osteogenic capacity to autografts back to levels observe

36 fibroblasts respond to injury by adopting an osteogenic cell fate and creating damaging calcific depo

37 ression of Runx2 and Col1a1, which are early osteogenic cell markers, on day 10 after the subperioste

38 Analogous to bone formation, osteogenic cells are thought to be recruited to the affe

39 differentiation efficiency and they generate osteogenic cells comparable to osteogenic cells derived

40 they generate osteogenic cells comparable to osteogenic cells derived from mesenchymal stromal cells

41 of pro-angiogenic potential of transplanted osteogenic cells for effective cell-mediated bone repair

42 tes potentially due to their derivation from osteogenic cells in the periosteum.

43 Osteogenic cells respond to mechanical changes in their

44 ults provide an insight into the response of osteogenic cells to individual substrate parameters and

45 ited normal bone morphology and responded to osteogenic chemical stimuli similar to wild-type mice.

46 tly their proliferation or influencing their osteogenic/chondrogenic differentiation.

47 ibition and siRNA knockdown of Ezh2 enhanced osteogenic commitment of MC3T3 preosteoblasts.

48 gent-based model of in vitro intramembranous osteogenic condensation.

49 e accumulation by overstimulating angiogenic-osteogenic coupling.

50 n osteoblasts and osteoclasts and angiogenic-osteogenic coupling.

51 The osteogenic default pathway may be subverted during patho

52 n of p53 in Wwox(Deltaosx1) mice rescued the osteogenic defect.

53 ropels the differentiation of MSCs toward an osteogenic destination.

54 ration and survival capacities, reduction in osteogenic differentiation and a decrease in the ability

55 able to significantly improve SHED-mediated osteogenic differentiation and immunomodulation.

56 lation of BMP4-pSMAD1/5 signaling, decreased osteogenic differentiation and lowered proliferation cap

57 of autophagy before day 3 strongly inhibited osteogenic differentiation and mineralization of ASCs in

58 dence that 25(OH)D3 at 250-500 nM can induce osteogenic differentiation and that 25(OH)D3 has great p

59 The expression of ZBTB16 during osteogenic differentiation and the expression of osteoge

60 g OA-mediated mesenchymal stromal cell (MSC) osteogenic differentiation are not known.

61 se of VEGFA in primary human MSCs to enhance osteogenic differentiation as a potential therapeutic.

62 ioactive, capable of stimulating odontogenic/osteogenic differentiation as observed by gene expressio

63 s induced by osteogenic stimuli and promotes osteogenic differentiation at least partly by targeting

64 tion in human smooth muscle cells undergoing osteogenic differentiation attenuated matrix mineralizat

65 Perturbation of SLC20a1 abrogates osteogenic differentiation by decreasing intramitochondr

66 mandibular asymmetry, are linked to an early osteogenic differentiation defect.

67 that these hESCs/hiPSCs are similar in their osteogenic differentiation efficiency and they generate

68 inB1-EphB2 interaction regulates odontogenic/osteogenic differentiation from dental pulp cells (DPCs)

69 ZBTB16 is associated with the process of osteogenic differentiation in bone marrow-derived mesenc

70 reported that alpha5beta1 integrin promotes osteogenic differentiation in mesenchymal skeletal cells

71 we examined effects of OA on cell viability, osteogenic differentiation in MSCs, and the involvement

72 th in MT, as mediated by enhanced MSC-driven osteogenic differentiation in the jaw bone.

73 ogenous TGFbeta1 receptor TGFbetaR1 impaired osteogenic differentiation in these MSCs.

74 g medium, which in turn efficiently enhanced osteogenic differentiation in vitro and osteointegration

75 PRP from alginate beads on BMP2-modified MSC osteogenic differentiation in vitro and sustained releas

76 ated a reduction in cell survival and direct osteogenic differentiation in vitro These effects were m

77 ced alpha5beta1 integrin priming can promote osteogenic differentiation independently of the RRET seq

78 shows that ZBTB16 induced the expression of osteogenic differentiation markers independently of RUNX

79 ogenic differentiation and the expression of osteogenic differentiation markers were assessed by real

80 The osteogenic differentiation of adipose-derived stem cells

81 ed Wnt/beta-catenin signaling which controls osteogenic differentiation of BMMSCs.

82 ively, our findings indicate Cdo1 suppresses osteogenic differentiation of BMSCs, through a potential

83 BMP-2, and promoted robust BMP-2-stimulated osteogenic differentiation of BMSCs.

84 gulation of E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs.

85 bone morphogenetic protein-2/BMP-2-directed osteogenic differentiation of bone marrow stromal cells

86 significantly improved potential for odonto/osteogenic differentiation of DPSCs both in vivo and in

87 in the process of IFN-gamma-regulated odonto/osteogenic differentiation of DPSCs.

88 Burn injury increases the predilection to osteogenic differentiation of ectopically implanted ossi

89 marrow stromal cells cultured in microwells, osteogenic differentiation of encapsulated cells depends

90 CSC-HUVEC contact significantly enhanced the osteogenic differentiation of FCSCs.

91 odel drug dexamethasone (Dex) to promote the osteogenic differentiation of hASCs.

92 ersed the promoting or suppressing effect of osteogenic differentiation of hBMSCs, respectively, caus

93 level was significantly increased during the osteogenic differentiation of hBMSCs.

94 e expression of miR-101 and its roles in the osteogenic differentiation of human bone marrow-derived

95 ohort of epigenetic regulators (>300) during osteogenic differentiation of human mesenchymal cells de

96 niques to synergistically improve growth and osteogenic differentiation of human mesenchymal stem cel

97 strated through localized cell spreading and osteogenic differentiation of human mesenchymal stem cel

98 easibility of our platform, we evaluated the osteogenic differentiation of human mesenchymal stem cel

99 e, we investigated the effect of 25(OH)D3 on osteogenic differentiation of human mesenchymal stem cel

100 BMP2-induced phosphorylation of Smad1/5 and osteogenic differentiation of human tenocytes in vitro.

101 and cartilage homeostasis by influencing the osteogenic differentiation of hypertrophic chondrocytes

102 of RhoA and ROCK activity partially restores osteogenic differentiation of IFT80-deficient OPCs by in

103 The increased osteogenic differentiation of mandibular torus MSCs was

104 well as on the adhesion, proliferation, and osteogenic differentiation of MC3T3-E1 pre-osteoblastic

105 find that cell spreading, proliferation, and osteogenic differentiation of mesenchymal stem cells (MS

106 es also showed enhanced ability in promoting osteogenic differentiation of mesenchymal stromal cells.

107 ally relevant mechanical stimulus, regulates osteogenic differentiation of MSCs through Transient rec

108 bone morphogenetic protein-2 (BMP2) promotes osteogenic differentiation of MSCs.

109 genesis by activating endothelialization and osteogenic differentiation of MSCs.

110 Osteogenic differentiation of primary human vascular smo

111 te (CaP) moieties have been shown to support osteogenic differentiation of stem and progenitor cells

112 he potential of plant-produced OPN to induce osteogenic differentiation of stem cells from periodonta

113 ed to have effects on both proliferation and osteogenic differentiation of stem cells.

114 proliferation and enhances the efficiency of osteogenic differentiation of the cells.

115 s did not alter their cytotoxicity or affect osteogenic differentiation of the stem cells.

116 7 (also known as osterix), and thus enhances osteogenic differentiation of these stem cells.

117 PDK4 augmented the osteogenic differentiation of VSMCs by phosphorylating S

118 ranscription (STAT) 3 signaling pathway, and osteogenic differentiation potential.

119 abolic compound, parbendazole, which induces osteogenic differentiation through a combination of cyto

120 FM550 and TPP diverted osteogenic differentiation toward adipogenesis in primar

121 Furthermore, BMP2 mediated MSC osteogenic differentiation was significantly enhance by

122 senchymal transition (EndoMT) and subsequent osteogenic differentiation with dramatically increased o

123 hogenic factors expressed by ESCs undergoing osteogenic differentiation yield a novel devitalized mat

124 in order to regulate their self-renewal and osteogenic differentiation, and H2S deficiency results i

125 atenin-independent defects in adipogenic and osteogenic differentiation, and knockdown of WTX reduced

126 ll LIV signals enhanced hBMSC proliferation, osteogenic differentiation, and upregulated genes associ

127 Genes crucial for osteogenic differentiation, bone matrix formation and mi

128 from Clec11a-deficient mice showed impaired osteogenic differentiation, but normal adipogenic and ch

129 ve Wnt signaling, including gene expression, osteogenic differentiation, cell migration, and antagoni

130 After osteogenic differentiation, expression levels of the tra

131 did not affect cell viability, apoptosis, or osteogenic differentiation, perhaps due to increased exp

132 Ppia(-/-) osteoblasts demonstrate decreased osteogenic differentiation, whereas Ppia(-/-) osteoclast

133 MiR-101 depletion suppressed osteogenic differentiation, whereas the overexpression o

134 role of magnesium in promoting CGRP-mediated osteogenic differentiation, which suggests the therapeut

135 DDT enhanced both adipogenic and osteogenic differentiation, which was confirmed by incre

136 After the initiation of osteogenic differentiation, ZBTB16 levels were increased

137 Interestingly, increased expression of osteogenic differentiation-related genes, including OSX,

138 Notch signaling fully blocked OA induced MSC osteogenic differentiation.

139 psazepine and SKF96365, which also inhibited osteogenic differentiation.

140 stem cells with SR2595 promotes induction of osteogenic differentiation.

141 Cell spread area was used as a measure of osteogenic differentiation.

142 ays an efficient mechano-modulation for MSCs osteogenic differentiation.

143 f histone 3 lysine 27 (H3K27me3), suppresses osteogenic differentiation.

144 At nontoxic doses, 1 promoted osteogenic differentiation.

145 o control the fate of human MSCs and enhance osteogenic differentiation.

146 d in DFCs downstream of ZBTB16 and after the osteogenic differentiation.

147 siologically stiff TCPS biases hMSCs towards osteogenic differentiation.

148 ced hMSCs was investigated by adipogenic and osteogenic differentiation.

149 and migration of DPSCs, but abrogated odonto/osteogenic differentiation.

150 ease, resulting in better cell in-growth and osteogenic differentiation.

151 l properties, drug release, degradation, and osteogenic differentiation.

152 hanism of autophagy in mesenchymal stem cell osteogenic differentiation.

153 iRNAs) are involved in multiple processes of osteogenic differentiation.

154 1.0 x 10(7)/mL stem cells exhibited the best osteogenic effect both in vitro and in vivo.

155 hat high-frequency acceleration (HFA) has an osteogenic effect on healthy alveolar bone.

156 These osteogenic effects are independent of glucocorticoids be

157 In this study, the in vitro osteogenic effects of polydopamine-laced hydroxyapatite

158 ition of Notch signaling is required for its osteogenic effects on MSCs.

159 Furthermore, we confirmed osteogenic efficacy of these Sterosomes loaded with nogg

160 arance and transformed the bone marrow to an osteogenic environment with enhanced PTH anabolism.

161 re implanted ectopically in combination with osteogenic factors into mice to generate a physiological

162 ation, these IS cells differentially express osteogenic factors, mechanosensitive genes, and signalin

163 Mechanical signals promote osteogenic fate through a primary cilia-mediated mechani

164 our results define the source of a critical osteogenic function in primary myelofibrosis that suppor

165 Msx2(fl/fl);LDLR(-/-) mice exhibited reduced osteogenic gene expression and mineralizing potential wi

166 yses of Mkx(-/-) PDL revealed an increase in osteogenic gene expression and no change in PDL- and inf

167 ng of the PDL space caused by an increase in osteogenic gene expression, a reduction in RANKL express

168 vivo validation of these pro-atherogenic and osteogenic genes also demonstrates a broad consistent di

169 o cooperative induction of expression of the osteogenic genes Col1a1, Fmod, and Ibsp.

170 1, which regulates the expression of key pro-osteogenic genes such as RUNX2 and BMP2.

171 verexpressing human PDL fibroblasts, whereas osteogenic genes were downregulated.

172 epress Wnt signaling alter the expression of osteogenic genes within the PDL space, which in turn aff

173 tretching (1%) and induced expression of two osteogenic genes, collagen Ia (Col1a) and osteopontin (O

174 multivalent dendrons containing a bioactive osteogenic growth peptide (OGP) domain and surface-bindi

175 Osteogenic histological analysis was performed by Safran

176 matches the expression changes observed for osteogenic hMSCs.

177 These condensations commit to an osteogenic identity and suppress chondrogenesis.

178 cing analyses, we found that genes vital for osteogenic identity were linked to RUNX2, C/EBPbeta, ret

179 evant scaffolds and microfluidic devices for osteogenic induction in the future.

180 ession in PDL-CD105(+) cells after 7 days of osteogenic induction, although mineral nodule formation

181 lkaline phosphatase, CD105, and CD166 during osteogenic induction.

182 PCL+FA and PCL scaffolds to investigate the osteogenic inductive ability of FA crystals and we obser

183 s was associated with further suppression of osteogenic lineage (Runx2, Sparc).

184 onse in a FZD-selective fashion, enhance the osteogenic lineage commitment of primary mouse and human

185 ndeed, biophysical stimuli potently regulate osteogenic lineage commitmentin vitro In this study, we

186 anobiology model, mechanical signals enhance osteogenic lineage commitmentin vivoand that the primary

187 ng a lineage autonomous function of Shox2 in osteogenic lineage fate determination and skeleton patte

188 wth factors to differentiate hMSCs toward an osteogenic lineage in situ.

189 ls to bone surfaces and the commitment to an osteogenic lineage of these cellsin vivo Furthermore, we

190 While aging impairs the osteogenic lineage, high-fat diet feeding activates expa

191 activity/osteoclastogenesis and promoter of osteogenic lineage, was used in H/R-exposed mice.

192 Harnessing an osteogenic lineage-specific Shox2 inactivation approach

193 ific result of Shox2 loss of function in the osteogenic lineage.

194 teoclast activity and recruitment, promoting osteogenic lineage.

195 VOCs prevented bone impairment and promoted osteogenic lineage.

196 he cellular identities of the adipogenic and osteogenic lineages of the bone.

197 clusive differentiation along adipogenic and osteogenic lineages, respectively.

198 rols mesenchymal cell fate into myogenic and osteogenic lineages.

199 as well as gene expression of Alpl and other osteogenic marker genes in mouse osteoblasts and mesench

200 Expressions of osteogenic marker genes including Osterix, but not Runx2

201 The expression level of early osteogenic marker genes, ALP, Runx2, and type I collagen

202 were accompanied by increased expression of osteogenic markers and intramembranous bone formation an

203 romotes vascular calcification by increasing osteogenic markers with no adverse effect on bone format

204 The osteogenic markers, alkaline phosphatase, secreted phosp

205 further required for eventual expression of osteogenic markers, and RARG-antagonist strongly drives

206 -treated mice showed decreased expression of osteogenic markers, coupled with an increase in osteocla

207 ombinations, that enhanced the expression of osteogenic markers.

208 th/differentiation through the activation of osteogenic master transcription factor Runx2, which is m

209 Osteogenic MC3T3-E1 cells were cultured on titanium disk

210 ved from EBs differentiated for 10 days with osteogenic media (+beta-glycerophosphate) exhibited simi

211 Samples were cultured in vitro in osteogenic media (OM) for 13 d and then implanted subcut

212 hear for 2 days and 3 &7 days in regular and osteogenic media, respectively.

213 ed rat bone marrow stromal cells cultured in osteogenic medium in which the normal 5.6 mm glucose is

214 times (every two days) on hASCs cultured in osteogenic medium over three weeks.

215 althy controls and cultured up to 24 d using osteogenic medium with standard phosphate concentration.

216 A common molecular marker for all osteogenic mesenchymal progenitors has not been identifi

217 icinity of the hematopoietic niche where the osteogenic milieu propels the differentiation of MSCs to

218 gnatures were identified and used to uncover osteogenic miRs of interest for osteoblast differentiati

219 from day 7, the upregulation of several pro-osteogenic molecules (dmp1, dspp, runx2, ocn, spp1, col1

220 An osteogenic Msx-Wnt regulatory program is concomitantly u

221 AJs) involving cancer-derived E-cadherin and osteogenic N-cadherin, the disruption of which abolishes

222 that disseminated breast cancer cells engage osteogenic niches in the bone through heterotypic adheri

223 t dental tissues have been described to have osteogenic/odontogenic-like differentiation capacity, bu

224 e specifically induced to differentiate down osteogenic or adipogenic pathways by controlling the con

225 PC-A cells were not osteogenic or adipogenic under standard differentiation

226 Condensation of pre-osteogenic, or pre-chondrogenic, cells is the first of a

227 cells, and allow their differentiation into osteogenic outcomes.

228 ly increased and expanded expression of many osteogenic pathway genes, including Bmp3, Bmp5, Bmp7, Me

229 that suggested a default preference for the osteogenic pathway; however, these patterns were rapidly

230 of AMC, suggesting that Runx2 and downstream osteogenic pathways in SMCs may be useful therapeutic ta

231 550 exposure with changes in adipogenic and osteogenic pathways.

232 Studies using an osteogenic patient-derived xenograft, MDA-PCa-118b, reve

233 experiments showed that H19 induces a strong osteogenic phenotype by altering the NOTCH1 pathway.

234 MC-specific Runx2 expression is required for osteogenic phenotype change and AMC remains unknown.

235 ata indicate a critical role of Runx2 in SMC osteogenic phenotype change and mineral deposition in a

236 n Runx2(f/f) mice expressed Runx2, underwent osteogenic phenotype change, and developed severe AMC.

237 Smooth muscle cell (SMC) transition to an osteogenic phenotype is a common feature of AMC, and is

238 pressed T63-induced RUNX2 expression and the osteogenic phenotypes.

239 zed lipid nanoparticles (LNPs) encapsulating osteogenic pleckstrin homology domain-containing family

240 ith limited differentiation capacity, having osteogenic potential (PC-O) or angiogenic support functi

241 ifferentiation characterized by an increased osteogenic potential and a TGFbeta1 signaling signature.

242 d the transfection efficiency, cytotoxicity, osteogenic potential and in vivo bone regenerative capac

243 esenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic gro

244 DLX3 mutation (c.533 A>G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal

245 demonstrated acceptable biocompatibility and osteogenic potential comparable to ABBM in vivo.

246 growth factor-associated genes and enhances osteogenic potential in PDLSCs.

247 The osteogenic potential of BMSCs treated with these polyple

248 ASA at 1,000 muM enhances osteogenic potential of PDLSCs.

249 ion toward progenitor cell lines with either osteogenic potential or pericyte-like angiogenic functio

250 The osteogenic potential was evaluated through mineralizatio

251 aspirin (ASA) on the proliferative capacity, osteogenic potential, and expression of growth factor-as

252 sed bone formation by compensating decreased osteogenic potentials with more generations and extended

253 ocess, mature osteoblasts dedifferentiate to osteogenic precursor cells and thus represent an importa

254 xc1 is preferentially expressed in the adipo-osteogenic progenitor CAR cells essential for haematopoi

255 and basic fibroblast growth factor in these osteogenic progenitor cells are markedly different, sugg

256 We evaluated osteogenic progenitor cells derived from both human embr

257 a femur non-union fracture demonstrate only osteogenic progenitor cells with higher pro-angiogenic p

258 c hedgehog (Shh) and Sca1, markers of aortic osteogenic progenitors, were also reduced, paralleling a

259 lpha and Sca-1 than the Sca-1-negative adipo-osteogenic progenitors, which create a niche for hematop

260 yltransferase, suppressed differentiation of osteogenic progenitors.

261 expression of this lncRNA, which promotes an osteogenic program by interfering with the expression of

262 ion of several Wnt genes, BMP2 activates the osteogenic program largely independently of de novo Wnt

263 positive feedback mechanism to activate the osteogenic program.

264 ort vascular mineralization by directing the osteogenic programming of aortic progenitors in diabetic

265 To examine the effects of osteogenic promoting conditions on DRP1 and whether DRP1

266 The study evaluates the osteogenic properties and biocompatibility of growth fac

267 the molecular mechanisms that regulate their osteogenic properties.

268 ic activity, cell density, collagen content, osteogenic protein expression, and organization of the t

269 Subsequently, CMP grafts with osteogenic protein-1 (OP-1) (test) and without OP-1 (con

270 h non-viral vectors harboring cmRNA encoding osteogenic proteins may be a powerful tool for stimulati

271 liferation of pre-osteoblasts, and stimulate osteogenic regulator/marker expression.

272 1 by siRNA led to an increased expression of osteogenic related genes, elevated alkaline phosphatase

273 A1, and NH4Cl) attenuated the expression of osteogenic related markers (osteopontin, alkaline phosph

274 electrical field stimulation (EFS)-enhanced osteogenic response in osteoprogenitor cells.

275 te the role of primary cilia in EFS-enhanced osteogenic response of human adipose-derived stem cells

276 to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone.

277 n levels, and knockdown of RUNX2 reduced the osteogenic role of T63.

278 ated respectively with greater expression of osteogenic RUNX2 and with lower expression of several in

279 Osteogenic sarcoma (OS) is a deadly skeletal malignancy

280 MP9 is also the most potent BMP for inducing osteogenic signaling in mesenchymal stem cells in vitro

281 th factors alone, we sustained mitogenic and osteogenic signals with these growth factors in an easil

282 vancing the targeted delivery selectivity of osteogenic siRNAs from the tissue level to the cellular

283 ect osteoblast-specific delivery systems for osteogenic siRNAs.

284 icone gels we show that harder gels are more osteogenic, softer gels are more adipogenic, and cell sp

285 hese data suggest that miR-101 is induced by osteogenic stimuli and promotes osteogenic differentiati

286 rogen deficiency (5 weeks), and exceeded the osteogenic strain threshold (10,000 muepsilon) in a simi

287 increased in Gja1(Jrt)/+ trabecular bone and osteogenic stromal cell cultures, which contributed to t

288 well as normal and abnormal development, of osteogenic structures.

289 The osteogenic subroutines later direct the growth and patte

290 ace (tissue culture plastic) with or without osteogenic supplements.

291 e present study investigates the role of the osteogenic transcription factor runt-related transcripti

292 cells and crucial for the expression of the osteogenic transcription factor runt-related transcripti

293 PDZ-binding domain (TAZ) as well as the pre-osteogenic transcription factor RUNX2 in human mesenchym

294 related transcription factor 2), encoding an osteogenic transcription factor, demonstrated some assoc

295 The osteogenic transcription factor, Runx2, is abnormally ex

296 iRNA transfection promoted the expression of osteogenic transcription factors in normal jaw bone MSCs

297 d restricted the Wnt3a induced expression of osteogenic transcriptional factors, such as Runx2 and Dl

298 differentiation with dramatically increased osteogenic transcriptional program and calcium depositio

299 ed with 5 x 10(5) rat EPCs and 5 x 10(5) rat osteogenic transformed MSCs (EPC/otMSCs) were fixed to t

300 utant pigs primarily developed lymphomas and osteogenic tumors, recapitulating the tumor types observ